Skip to main content
main-content

01.12.2018 | Primary Research | Ausgabe 1/2018 Open Access

Cancer Cell International 1/2018

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells

Zeitschrift:
Cancer Cell International > Ausgabe 1/2018
Autoren:
Ekapot Singsuksawat, Chanitra Thuwajit, Komgrid Charngkaew, Peti Thuwajit
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1186/​s12935-018-0525-z) contains supplementary material, which is available to authorized users.

Abstract

Background

Cholangiocarcinoma (CCA) is one of the worst prognosis cancer. The survival time of CCA patients is related to serum estrogen levels and estrogen has been found to enhance the proliferation and invasiveness of CCA cells in vitro. This has led to the suggestion that estrogen may play an important role in the progression of CCA. This study tests the relevance of the previous in vitro findings in vivo using a mouse xenograft model of CCA, and investigates possible signaling mechanisms involved.

Methods

KKU-213 and KKU-139 CCA cell lines were used in the experiments, xenografted to nude mice and treated with a potent estrogenic agent, 17β-estradiol (E2), and/or with tamoxifen (TAM), an estrogen antagonist.

Results

The results demonstrated that E2 could accelerate growth of the xenograft-tumor and the effect was inhibited by TAM. PCR array screening of E2 responsive genes suggested ETV4 as a promising candidate intracellular mediator. ETV4-knockdown CCA cells were generated and these showed a diminished responsiveness to E2 in both cell and spheroid proliferation assays, and in invasion tests. These results point to ETV4 as a possible mediator of E2-activated CCA progression and as a potential target of TAM-mediated inhibition.

Conclusions

Finally, TAM may be suggested as an adjunctive treatment of CCA to improve the conventional cytotoxic method with more patient toleration.
Zusatzmaterial
Additional file 1: Table S1. Primer sequences for gene expression analysis of ERs. Figure S1. Relative expression of ERs in CCA cells compared to MCF-7 and MDA-MB-231 breast cancer cells: (A) ER-α; (B) ER-β. Figure S2. Efficacy of shETV4 plasmid transfection and knockdown: (A) Transfection efficacy determined by expression of GFP and visualized under fluorescence inverted microscope with 40x original magnification, cell type and conditions were labelled in the picture; (B) Knockdown efficacy in transfected cells determined by RT-real time PCR and compared to parental cell mRNA.
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 1/2018

Cancer Cell International 1/2018 Zur Ausgabe